Neurocognitive Disorders Clinical Trial
Official title:
Efficacy of the Memory Motivation (MEMO) Web Application for Cognitive and Behavioral Training in Patients With Neurocognitive Disorders
Memory, attentional, and behavioural symptoms are the clinical hallmarks of Neurocognitive
disorders (NCD) such as Alzheimer's disease and related disorders. The World Health
Organisation (WHO) guidelines for risk reduction of cognitive decline and dementia indicate
that Cognitive training may be offered to older adults with normal cognition and with mild
cognitive impairment to reduce the risk of cognitive decline and/or dementia. The use of
Information and Communication Technologies (ICT) in the health domain is progressively
expanding. The Alzheimer Innovation Association have developed MeMo (Memory Motivation) a
free web application that can be used at home by patients.
The objective of the present study was to assess the effectiveness of employing the MeMo
platform on cognitive performance in patients suffering from NCD.
The objective of this study is to evaluate the effectiveness of the MeMo cognitive training exercise platform in patients suffering from neurocognitive disorders. These exercises ,have been developed by the association Innovation Alzheimer and the CoBTeK research team, located with the Nice memory Center at the Institut Claude Pompidou. MeMo can be used freely at home by patients. More specifically, it is a randomized controlled study that aims to compare the evolution of activities cognition and behavior between patients not using these exercises, and patients using these exercises for 12 weeks, 4 sessions per week. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05754567 -
CONCEPTT Kids International Neurodevelopmental Outcomes Among Offspring of Women With Type 1 Diabetes
|
||
Completed |
NCT05080777 -
Pilot Pragmatic Clinical Trial to Embed Tele-Savvy Into Health Care Systems
|
N/A | |
Not yet recruiting |
NCT03276377 -
VItamin K Inhibition and NeurocoGnition (VIKING)
|
N/A | |
Completed |
NCT04175223 -
Impact of Probiotics in HIV-positive Patients With Neurocognitive Disorders
|
N/A | |
Completed |
NCT03538522 -
A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831
|
Phase 2 | |
Recruiting |
NCT05732285 -
A Pilot Randomized Controlled Trial: CoINTEGRATE
|
N/A | |
Recruiting |
NCT04095962 -
Effects of a Multicomponent Exercise Intervention on Physical and Cognitive Function of Older Adults With Dementia
|
N/A | |
Not yet recruiting |
NCT04113577 -
COgilus Remediation in Alzheimer Patients (CORA)
|
||
Recruiting |
NCT06320639 -
DRIVing Simulator and People With NeuroCognitive Disorders
|
||
Recruiting |
NCT06105320 -
COGNIFOOD-Changing the Carbohydrate/Fat-ratio to Prevent Cognitive Decline and Alzheimer Pathology: A Pilot Study
|
N/A | |
Completed |
NCT03050385 -
Cognitive Rehabilitation During Transcranial Direct Current Stimulation
|
N/A | |
Active, not recruiting |
NCT06372002 -
Effectiveness and Cost-Effectiveness of Cognitive Stimulation Therapy - Spain (CST-ES) in People Living With Dementia
|
N/A | |
Recruiting |
NCT05508789 -
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)
|
Phase 3 | |
Recruiting |
NCT03926351 -
High Dose Omega 3 in People at Risk for Dementia
|
Phase 2 | |
Recruiting |
NCT05504681 -
Integration of Neurocognitive Biomarkers Into a Neuro-Oncology Clinic
|
||
Completed |
NCT04168268 -
Patient-reported Outcome Measures After Post-anesthesia Care Unit Delirium
|
||
Recruiting |
NCT04825847 -
Neurocognitive Disorders After Major Surgery in Elderly
|
N/A | |
Active, not recruiting |
NCT02958670 -
Imaging Tau Deposition in the Brain of Elderly Subjects
|
N/A | |
Enrolling by invitation |
NCT02652598 -
Evaluate the Effects of Tolcapone on Cognitive and Behavioral Dysfunction in Patients With BI and NCD
|
Phase 2 | |
Completed |
NCT02825732 -
MEMORA-Caregiver : Risk Factors of Caregiver Burden Among Patients With Neurocognitive Disorders or Subjective Cognitive Complaint
|
N/A |